Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2020 Filed Jan 17, 2020 12:41 UTC |
Wade M. AndrewSVP and CFO
|
SaleCommon Stock | 10,000 | $36.00 | $360,000.00 |
DisclosureSEC source: 0001209191-20-003794 · doc4.xml · nonDerivative · entry 2 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,120 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| January 16, 2020 Filed Jan 17, 2020 12:41 UTC |
Wade M. AndrewSVP and CFO
|
Exercise / conversionCommon Stock | 10,000 | $6.27 | $62,700.00 |
DisclosureSEC source: 0001209191-20-003794 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| January 16, 2020 Filed Jan 17, 2020 12:44 UTC |
Seith Douglas JChief Operating Officer
|
SaleCommon Stock | 25,471 | $36.00 | $916,956.00 |
DisclosureSEC source: 0001209191-20-003796 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,272 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| January 15, 2020 Filed Jan 16, 2020 12:22 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001209191-20-003566 · doc4.xml · derivative · entry 6 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2022-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. F3 · derivative.exercise_date: These options were granted on November 1, 2012 and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| January 15, 2020 Filed Jan 16, 2020 12:22 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
SaleCommon Stock | 25,000 | $35.00 | $875,000.00 |
DisclosureSEC source: 0001209191-20-003566 · doc4.xml · nonDerivative · entry 4 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626,490 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| January 15, 2020 Filed Jan 16, 2020 12:22 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
Exercise / conversionCommon Stock | 25,000 | $5.91 | $147,750.00 |
DisclosureSEC source: 0001209191-20-003566 · doc4.xml · nonDerivative · entry 3 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 651,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 07:38 UTC |
Collar Mark ADirector
|
SaleCommon Stock | 4,000 | $35.02 | $140,080.00 |
DisclosureSEC source: 0001209191-20-003792 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,106 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.00 to $35.09 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 12:22 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001209191-20-003566 · doc4.xml · derivative · entry 5 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 25,000 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. F3 · derivative.exercise_date: These options were granted on November 1, 2012 and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 12:22 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
SaleCommon Stock | 25,000 | $34.00 | $850,000.00 |
DisclosureSEC source: 0001209191-20-003566 · doc4.xml · nonDerivative · entry 2 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626,490 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 12:22 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
Exercise / conversionCommon Stock | 25,000 | $5.91 | $147,750.00 |
DisclosureSEC source: 0001209191-20-003566 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 651,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 12:55 UTC |
Wade M. AndrewSVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $6.27 | $0.00 |
DisclosureSEC source: 0001209191-20-003571 · doc4.xml · derivative · entry 3 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 10,000 shares Expires 2022-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. F3 · derivative.exercise_date: These options were granted on October 25, 2012. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 12:55 UTC |
Wade M. AndrewSVP and CFO
|
SaleCommon Stock | 10,000 | $34.00 | $340,000.00 |
DisclosureSEC source: 0001209191-20-003571 · doc4.xml · nonDerivative · entry 2 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,120 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 12:55 UTC |
Wade M. AndrewSVP and CFO
|
Exercise / conversionCommon Stock | 10,000 | $6.27 | $62,700.00 |
DisclosureSEC source: 0001209191-20-003571 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 12:31 UTC |
Seith Douglas JChief Operating Officer
|
SaleCommon Stock | 36,363 | $34.00 | $1,236,342.00 |
DisclosureSEC source: 0001209191-20-003569 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,743 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.00 to $34.08 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 12:34 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.30 | $0.00 |
DisclosureSEC source: 0001209191-20-001471 · doc4.xml · derivative · entry 4 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 15,000 shares Expires 2024-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 12:34 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
SaleCommon Stock | 14,134 | $32.89 | $464,867.26 |
DisclosureSEC source: 0001209191-20-001471 · doc4.xml · nonDerivative · entry 3 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,434 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $32.57 to $33.00 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 12:34 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
SaleCommon Stock | 15,000 | $32.89 | $493,350.00 |
DisclosureSEC source: 0001209191-20-001471 · doc4.xml · nonDerivative · entry 2 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,568 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $32.60 to $33.00 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 12:34 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
Exercise / conversionCommon Stock | 15,000 | $18.30 | $274,500.00 |
DisclosureSEC source: 0001209191-20-001471 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 12:36 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 23,546 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001209191-20-001473 · doc4.xml · derivative · entry 3 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 23,546 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. F4 · derivative.exercise_date: These options were granted on November 1, 2012 and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 12:36 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
SaleCommon Stock | 23,546 | $33.00 | $777,018.00 |
DisclosureSEC source: 0001209191-20-001473 · doc4.xml · nonDerivative · entry 2 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626,490 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $33.00 to $33.01 per share. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 12:36 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
Exercise / conversionCommon Stock | 23,546 | $5.91 | $139,156.86 |
DisclosureSEC source: 0001209191-20-001473 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:13 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GrantCommon Stock | 387 | $25.99 | $10,058.13 |
DisclosureSEC source: 0001209191-20-000861 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626,490 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2019. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2019, which was the first trading day of the applicable offering period. The closing price on July 1, 2019 was $30.58. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:27 UTC |
Privitera SalvatoreChief Technology Officer
|
GrantCommon Stock | 108 | $25.99 | $2,806.92 |
DisclosureSEC source: 0001209191-20-000967 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,139 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2019. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2019, which was the first trading day of the applicable offering period. The closing price on July 1, 2019 was $30.58. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:09 UTC |
Wade M. AndrewSVP and CFO
|
GrantCommon Stock | 405 | $25.99 | $10,525.95 |
DisclosureSEC source: 0001209191-20-000816 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,120 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2019. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2019, which was the first trading day of the applicable offering period. The closing price on July 1, 2019 was $30.58. Read SEC document |
| December 26, 2019 Filed Dec 30, 2019 12:46 UTC |
Seith Douglas JChief Operating Officer
|
SaleCommon Stock | 31,440 | $32.00 | $1,006,080.00 |
DisclosureSEC source: 0001209191-19-062053 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,106 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| December 26, 2019 Filed Dec 30, 2019 12:49 UTC |
Wade M. AndrewSVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $11.20 | $0.00 |
DisclosureSEC source: 0001209191-19-062055 · doc4.xml · derivative · entry 3 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2021-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. F3 · derivative.exercise_date: This option was granted on February 9, 2011. The option vests and is exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| December 26, 2019 Filed Dec 30, 2019 12:49 UTC |
Wade M. AndrewSVP and CFO
|
SaleCommon Stock | 1,000 | $32.00 | $32,000.00 |
DisclosureSEC source: 0001209191-19-062055 · doc4.xml · nonDerivative · entry 2 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,715 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| December 26, 2019 Filed Dec 30, 2019 12:49 UTC |
Wade M. AndrewSVP and CFO
|
Exercise / conversionCommon Stock | 1,000 | $11.20 | $11,200.00 |
DisclosureSEC source: 0001209191-19-062055 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:20 UTC |
Florin Daniel PDirector
|
GrantCommon Stock | 5,902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-059294 · doc4.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,902 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 33% annually over three years from date of grant. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:24 UTC |
Prange KarenDirector
|
GrantCommon Stock | 5,902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-059298 · doc4.xml · nonDerivative · entry 1 Prange Karen · CIK 0001566083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,902 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 33% annually over three years from date of grant. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:53 UTC |
Wade M. AndrewSVP and CFO
|
SaleCommon Stock | 11,705 | $30.00 | $351,150.00 |
DisclosureSEC source: 0001209191-19-058142 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,715 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 20:53 UTC |
Seith Douglas JChief Operating Officer
|
SaleCommon Stock | 5,235 | $25.51 | $133,544.85 |
DisclosureSEC source: 0001209191-19-050084 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,546 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $25.16 to $25.89 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 20:53 UTC |
Seith Douglas JChief Operating Officer
|
SaleCommon Stock | 43,569 | $25.65 | $1,117,544.85 |
DisclosureSEC source: 0001209191-19-050084 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,281 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.15 to $25.91 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 11:28 UTC |
GROVES REGINA EDirector
|
PurchaseCommon Stock | 500 | $24.86 | $12,430.00 |
DisclosureSEC source: 0001209191-19-049552 · doc4.xml · nonDerivative · entry 1 GROVES REGINA E · CIK 0001653877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,670 F1 · price: This transaction was executed in multiple trades at prices ranging from $24.82 to $24.87 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 09, 2019 Filed Sep 10, 2019 11:50 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-048988 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626,103 F1 · price: No consideration was received in connection with this gift to charity. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 11:46 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-046245 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,568 F1 · price: No consideration was received in connection with this gift to charity. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 20:40 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,454 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001209191-19-044273 · doc4.xml · derivative · entry 3 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,546 Underlying: Common Stock · 1,454 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. F3 · derivative.exercise_date: These options were granted on November 1, 2012 and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 20:40 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
SaleCommon Stock | 1,454 | $33.00 | $47,982.00 |
DisclosureSEC source: 0001209191-19-044273 · doc4.xml · nonDerivative · entry 2 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636,103 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 20:40 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
Exercise / conversionCommon Stock | 1,454 | $5.91 | $8,593.14 |
DisclosureSEC source: 0001209191-19-044273 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 637,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 11:38 UTC |
Privitera SalvatoreChief Technology Officer
|
Tax withholdingCommon Stock | 6,596 | $32.52 | $214,501.92 |
DisclosureSEC source: 0001209191-19-043292 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,031 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 12:30 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001209191-19-041875 · doc4.xml · derivative · entry 3 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 25,000 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. F4 · derivative.exercise_date: These options were granted on November 1, 2012 and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 12:30 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
SaleCommon Stock | 25,000 | $32.00 | $800,000.00 |
DisclosureSEC source: 0001209191-19-041875 · doc4.xml · nonDerivative · entry 2 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636,103 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $32.00 to $32.01 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 12:30 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
Exercise / conversionCommon Stock | 25,000 | $5.91 | $147,750.00 |
DisclosureSEC source: 0001209191-19-041875 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 661,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| June 30, 2019 Filed Jul 3, 2019 01:13 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GrantCommon Stock | 435 | $25.36 | $11,031.60 |
DisclosureSEC source: 0001209191-19-040612 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636,103 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2019. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2019, which was the last trading day of the applicable offering period. The closing price on June 28, 2019 was $29.84. Read SEC document |
| June 30, 2019 Filed Jul 3, 2019 01:18 UTC |
Privitera SalvatoreChief Technology Officer
|
GrantCommon Stock | 717 | $25.36 | $18,183.12 |
DisclosureSEC source: 0001209191-19-040617 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,627 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2019. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2019, which was the last trading day of the applicable offering period. The closing price on June 28, 2019 was $29.84. Read SEC document |
| June 30, 2019 Filed Jul 3, 2019 01:16 UTC |
Wade M. AndrewSVP and CFO
|
GrantCommon Stock | 407 | $25.36 | $10,321.52 |
DisclosureSEC source: 0001209191-19-040615 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,420 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2019. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2019, which was the last trading day of the applicable offering period. The closing price on June 28, 2019 was $29.84. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 11:03 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
SaleCommon Stock | 10,000 | $30.00 | $300,000.00 |
DisclosureSEC source: 0001209191-19-037902 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,068 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| June 05, 2019 Filed Jun 6, 2019 11:03 UTC |
Wade M. AndrewSVP and CFO
|
SaleCommon Stock | 10,107 | $30.00 | $303,210.00 |
DisclosureSEC source: 0001209191-19-034969 · doc4.xml · nonDerivative · entry 2 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,013 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 11:03 UTC |
Wade M. AndrewSVP and CFO
|
SaleCommon Stock | 704 | $30.00 | $21,120.00 |
DisclosureSEC source: 0001209191-19-034969 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,120 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| May 22, 2019 Filed May 24, 2019 08:51 UTC |
Collar Mark ADirector
|
GrantCommon Stock | 4,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032580 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,106 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.